Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells.
about
Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010-2015)Advancing functional engineered cardiac tissues toward a preclinical model of human myocardium.Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell TherapyMeasuring cell-generated forces: a guide to the available toolsA microfabricated magnetic actuation device for mechanical conditioning of arrays of 3D microtissuesHuman Engineered Cardiac Tissues Created Using Induced Pluripotent Stem Cells Reveal Functional Characteristics of BRAF-Mediated Hypertrophic Cardiomyopathy.Three-dimensional elastomeric scaffolds designed with cardiac-mimetic structural and mechanical features.Regulating tension in three-dimensional culture environmentsConcise review: drug discovery in the age of the induced pluripotent stem cell.Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms.Cardiac tissue engineering: renewing the arsenal for the battle against heart disease.Valve interstitial cell tensional homeostasis directs calcification and extracellular matrix remodeling processes via RhoA signaling.Machine Learning of Human Pluripotent Stem Cell-Derived Engineered Cardiac Tissue Contractility for Automated Drug Classification.Collagen scaffold enhances the regenerative properties of mesenchymal stromal cells.Physiologic, Pathologic, and Therapeutic Paracrine Modulation of Cardiac Excitation-Contraction Coupling.Coronary Capillary Blood Flow in a Rat Model of Congestive Heart Failure.CXCR4 and CXCR7 play distinct roles in cardiac lineage specification and pharmacologic β-adrenergic response.
P2860
Q26748751-4CFE8005-5C2A-44AC-BBF2-1E7974CE896EQ30566351-4EB233A4-5E21-4D1E-95AF-D9F9836FA485Q31056955-2DECC71B-82E4-422C-BDEF-7CFA0EAC55A5Q33809070-0B9534C2-D462-4797-AC67-78B844B0039EQ35629839-FD458124-92A7-4403-8938-35DDCA4ECBC1Q35897783-4DDC4A4C-A636-45E0-86AC-6AB3A22D3A90Q36593683-A9ED456C-248D-4623-8056-982C7F2E523EQ37421954-5D3BB310-43D1-4ACF-8F78-4D429201BFA8Q37680999-AB9CA934-FBD3-4408-96FB-646ED1533128Q38009276-4465D221-7ED8-4D27-BE8D-13655EE787CFQ38172390-C1AFE97E-CFB7-4C21-B352-AB4077F2D310Q41634289-4CCD9AA3-0DD7-4F06-8735-DC1B574EED4AQ45944962-5D426D06-1314-42FC-8189-A30497CDE5B4Q47157786-D3406055-7853-43F3-993F-5C3B18E5FB5CQ47200001-A12F465D-857F-4A5A-982B-410181F90E27Q47639654-47E2542F-248D-4345-9A3B-AC4F0656EA41Q50888759-0DFC1790-4618-476E-B0C1-E35C32412A10
P2860
Myocyte-depleted engineered cardiac tissues support therapeutic potential of mesenchymal stem cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Myocyte-depleted engineered ca ...... ial of mesenchymal stem cells.
@ast
Myocyte-depleted engineered ca ...... ial of mesenchymal stem cells.
@en
type
label
Myocyte-depleted engineered ca ...... ial of mesenchymal stem cells.
@ast
Myocyte-depleted engineered ca ...... ial of mesenchymal stem cells.
@en
prefLabel
Myocyte-depleted engineered ca ...... ial of mesenchymal stem cells.
@ast
Myocyte-depleted engineered ca ...... ial of mesenchymal stem cells.
@en
P2093
P2860
P1476
Myocyte-depleted engineered ca ...... ial of mesenchymal stem cells.
@en
P2093
Damian Ancukiewicz
Do Eun Kim
Gregory W Serrao
Irene C Turnbull
Kevin D Costa
Lahouaria Hadri
Roger J Hajjar
Timothy J Cashman
P2860
P304
P356
10.1089/TEN.TEA.2011.0278
P577
2012-06-25T00:00:00Z